Carcinogenesis Advance Access published online on February 12, 2006
Carcinogenesis, doi:10.1093/carcin/bgi360
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Clinical Genetics, University of Oulu/Oulu University Hospital, Oulu, Finland
* To whom correspondence should be addressed. The Mre11 complex, composed of RAD50, NBS1 and MRE11, has an essential role in the maintenance of genomic integrity and preventing cells from malignancy. Here we report the association of three Mre11 complex mutations with hereditary breast cancer susceptibility, studied by using a case-control design with 317 consecutive, newly diagnosed Northern Finnish breast cancer patients and 1000 geographically matched healthy controls (P=0.0004). RAD50 687delT displayed significantly elevated frequency in the studied patients (8/317, OR 4.3, 95% CI 1.5-12.5, P=0.008), which indicates that it is a relatively common low-penetrance risk allele in this cohort. Haplotype analysis and the screening of altogether 512 additional breast cancer cases from Sweden, Norway and Iceland suggest that RAD50 687delT is a Finnish founder mutation, not present in the other Nordic cohorts. The RAD50 IVS3-1G>A splicing mutation leading to translational frameshift was observed in one patient, and the NBS1 Leu150Phe missense mutation affecting a conserved residue in the functionally important BRCT domain in two patients, both being absent from 1000 controls. Microsatellite marker analysis showed that loss of the wild type allele was not involved in the tumorigenesis in any of the studied mutation carriers, but they all showed increased genomic instability assessed by cytogenetic analysis of peripheral blood T-lymphocytes (P=0.006). In particular, the total number of chromosomal rearrangements was significantly increased (P=0.002). These findings suggest an effect for RAD50 and NBS1 haploinsufficiency on genomic integrity and susceptibility to cancer.
Received November 15, 2005
Revised January 24, 2006
Accepted January 28, 2006
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Katri Heikkinen 1,
Katrin Rapakko 1,
Sanna-Maria Karppinen 1,
Hannele Erkko 1,
Sakari Knuutila 2,
Tuija Lundán 3,
Arto Mannermaa 1,
Anne-Lise Børresen-Dale 4,
Åke Borg 5,
Rosa B. Barkardottir 6,
John Petrini 7,
and
Robert Winqvist 1 *
2 Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB Helsinki University Central Hospital, Finland
3 Department of Clinical Genetics, University of Oulu/Oulu University Hospital, Oulu, Finland; Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB Helsinki University Central Hospital, Finland
4 Department of Genetics, Norwegian Radium Hospital, Oslo, Norway
5 Department of Oncology, Lund University Hospital, Lund, Sweden
6 Department of Pathology, University Hospital of Iceland, Reykjavik, Iceland
7 Department of Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Robert Winqvist, E-mail: robert.winqvist{at}oulu.fi
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. J. Garcia, V. Fernandez, A. Osorio, A. Barroso, F. Fernandez, M. Urioste, and J. Benitez Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition Carcinogenesis, November 1, 2009; 30(11): 1898 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hofer, R. Kuefer, C. Maier, K. Herkommer, S. Perner, F. Demichelis, T. Paiss, W. Vogel, M. A. Rubin, and J. Hoegel Genome-Wide Linkage Analysis of TMPRSS2-ERG Fusion in Familial Prostate Cancer Cancer Res., January 15, 2009; 69(2): 640 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Nicolo, M. Tancredi, G. Lombardi, C. C. Flemma, S. Barbuti, C. Di Cristofano, B. Sobhian, G. Bevilacqua, R. Drapkin, and M. A. Caligo A Novel Breast Cancer-Associated BRIP1 (FANCJ/BACH1) Germ-line Mutation Impairs Protein Stability and Function Clin. Cancer Res., July 15, 2008; 14(14): 4672 - 4680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, M. A. Grotzer, T. Watanabe, E. Hewer, T. Pietsch, S. Rutkowski, and H. Ohgaki Mutations in the Nijmegen Breakage Syndrome Gene in Medulloblastomas Clin. Cancer Res., July 1, 2008; 14(13): 4053 - 4058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, C. Szabo, C. Qian, P. G. Amadio, S. N. Thibodeau, J. R. Cerhan, G. M. Petersen, W. Liu, and F. J. Couch Mutational Analysis of Thirty-two Double-Strand DNA Break Repair Genes in Breast and Pancreatic Cancers Cancer Res., February 15, 2008; 68(4): 971 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-M. Hsu, H.-C. Wang, S.-T. Chen, G.-C. Hsu, C.-Y. Shen, and J.-C. Yu Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2024 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yoon, Y. Yang, J. Choi, and J. Seong Large scale data mining approach for gene-specific standardization of microarray gene expression data Bioinformatics, December 1, 2006; 22(23): 2898 - 2904. [Abstract] [Full Text] [PDF]
|
|